Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$43,874,333
+$42,281,319 QoQ
Shares Held
172,754
+2550.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.90%
of 13F equity value
Holder Rank
#475
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SNS Financial Group, LLC holds $152,677,395 across 10 Drug Manufacturers - General names. JNJ ranks #2 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,863 | $56,208,892 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
172,754 | $43,874,333 | |
| 3 | NVO |
Novo Nordisk A S
|
669,858 | $32,112,992 | |
| 4 | ABBV |
AbbVie Inc.
|
32,457 | $8,167,479 | |
| 5 | PFE |
Pfizer Inc
|
167,096 | $4,023,671 | |
| 6 | MRK |
Merck & Co., Inc.
|
27,952 | $3,591,832 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,127 | $2,081,637 | |
| 8 | AMGN |
Amgen Inc
|
2,842 | $1,029,145 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,874,333 | 172,754 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,593,014 | 6,517 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,342,277 | 6,486 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $1,162,954 | 6,272 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,029,076 | 6,737 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,127,380 | 6,798 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $943,934 | 6,527 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $1,129,233 | 6,968 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,061,412 | 7,262 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,127,261 | 7,126 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,085,737 | 6,927 | Shares | Defined | 2024-01-22 | |
| 2023-09-30 | $1,060,657 | 6,810 | Shares | Defined | 2023-10-19 | |
| 2023-06-30 | $1,100,542 | 6,649 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,065,935 | 6,877 | Shares | Defined | 2023-04-28 | |
| 2022-12-31 | $1,609,104 | 9,109 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $1,420,741 | 8,697 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,533,153 | 8,637 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,513,543 | 8,540 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,462,134 | 8,547 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,380,825 | 8,550 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,467,668 | 8,909 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,414,724 | 8,608 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,360,863 | 8,647 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $1,276,347 | 8,573 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,186,213 | 8,435 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $1,092,837 | 8,334 | Shares | Defined | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||